Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3YLVINYL)pyrimidine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8604191
APP PUB NO 20110281895A1
SERIAL NO

13129898

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-yl)pyrimidine, novel salt forms, and novel polymorphic forms of these salts.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OYSTER POINT PHARMA INC202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Akireddy, Srinivasa Rao Winston-Salem, US 25 81
Bhatti, Balwinder Singh Winston-Salem, US 51 330
Cuthbertson, Timothy J Winston-Salem, US 13 57
Dull, Gary Maurice Lewisville, US 75 743
Miller, Craig Harrison Winston-Salem, US 38 392
Mitchener,, Jr Joseph Pike Winston-Salem, US 13 92
Munoz, Julio A Walnut Cove, US 34 269
Otten, Pieter Albert King, US 11 47

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 10, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00